share

7H-Diimidazo[1,5-A:1,5,4-De]Quinoxaline(9Ci) CAS NO 177528-39-1


Unit Price:

CAS No.:177528-39-1

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

7H-Diimidazo[1,5-A:1,5,4-De]Quinoxaline(9Ci) is a specialized heterocyclic organic compound with a fused polycyclic structure, serving as a key advanced intermediate in modern synthetic chemistry. Its unique molecular architecture makes it a valuable building block for the development of novel materials and active pharmaceutical ingredients (APIs). This high-purity compound is essential for researchers and manufacturers in the pharmaceutical, agrochemical, and advanced materials sectors seeking to innovate and synthesize complex molecules.

Application

  • Pharmaceutical Intermediate: A critical precursor in the synthesis of novel drug candidates, particularly those targeting neurological disorders or acting as kinase inhibitors.
  • Agrochemical Research: Used in the development of new pesticides and herbicides, leveraging its heterocyclic core for biological activity.
  • Organic Light-Emitting Diodes (OLEDs): Serves as a potential electron-transport or host material in the fabrication of OLED devices due to its rigid, conjugated structure.
  • Coordination Chemistry & Ligand Synthesis: Acts as a versatile ligand or precursor for creating metal-organic frameworks (MOFs) and catalysts.
  • Dye & Pigment Industry: Employed in the synthesis of advanced colorants and fluorescent dyes.
  • Academic & Industrial R&D: A valuable compound for methodological studies in organic synthesis and heterocyclic chemistry.

Basic Information

Product Name 7H-Diimidazo[1,5-A:1,5,4-De]Quinoxaline(9Ci)
CAS No. 177528-39-1
Molecular Formula C11H6N4
Molecular Weight 194.19 g/mol
Synonyms 7H-Diimidazo[1,5-a:1',5'-d]quinoxaline; Diimidazoquinoxaline; 7H-Diimidazo[1,5-a:1,5-d]quinoxaline; 177528-39-1; Quinoxaline, 7H-diimidazo[1,5-a:1',5'-d]-; SCHEMBL2180901; BCP23833; AKOS005259155
EINECS Contact for details

Quality Control

Our 7H-Diimidazo[1,5-A:1,5,4-De]Quinoxaline(9Ci) is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC, NMR, and mass spectrometry, to ensure high purity and batch-to-batch consistency. Certificates of Analysis (COA) detailing all specifications are provided and available upon request to support your quality assurance and regulatory compliance needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from heat and incompatible materials.

Specification

Item Specification
Appearance Off-white to light yellow powder
Identification (IR) Conforms to structure
Identification (HPLC) Conforms to reference
Purity (HPLC) ≥ 97.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.